Lean body mass may protect against prostate cancer

A high lean body mass - calculated using an equation to determine body mass minus the fat—may lower the risk of prostate cancer, a new study indicates.

Prostate cancer is a hormone-related disease affected by a variety of other factors including genetics, age, ethnicity and family history. In the last few years, researchers started to suspect that body size might also affect the risk of prostate cancer, but research has provided conflicting results.

Most studies investigated body mass index, but this index includes lean and fat tissue, which may have different influences on the risk of cancer.

In an attempt to settle things, Dr. John S. Witte from the University of California, San Francisco, and his colleagues conducted a study of 439 men with prostate cancer and 479 of their siblings without prostate cancer.

They examined the effects of weight, height, body mass index, and lean body mass, which they thought might be more relevant than body mass index to the risk of prostate cancer and aggressiveness of the disease.

The researchers found that the higher the lean body mass, the lower the risk of prostate cancer, especially in men with more aggressive disease or who were older when their cancer was diagnosed. They also observed a similar, though weaker, inverse pattern for weight, but found no associations between risk of prostate cancer and body mass index or height.

The investigators suspect that the inverse associations between higher lean body mass and prostate cancer risk may reflect the potentially protective effect of high levels of the male hormone androgen in patients with high lean body mass on the development and progression of prostate cancer.

SOURCE: Journal of Urology, December 2005.

RELATED STORIES:
Researchers Uncover How Prostate Cancer Cells Defy Death   Newly Discovered Gene Fusion May Lead to Improved Prostate Cancer Diagnosis   Neither Vitamin C or E Associated With Reduced Risk of Prostate Cancer, or Other Cancers   Exercise Reduces Death Rate in Prostate Cancer Patients   Generic Prostate Drug Helps Find High-risk Cancers Early   Prostate cancer therapy linked to increased risk of heart disease death   Shorter radiation course as effective as standard therapy for prostate cancer recurrence   Pomegranate Juice Slows PSA Acceleration Rate After Prostate Cancer Surgery, Radiation   Younger men do well with prostate cancer surgery   Many prostate cancer patients receive improper or ‘mismatched’ therapies   Mushroom extract may boost prostate cancer drug   Prostate cancer anxiety may affect therapy choices   Selenium-Protein Deficiency Raises Prostate Cancer Risk   Family counseling improves lives of patients and spouses coping with prostate cancer   CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer   Men often not told of prostate cancer risks: study   New data show benefit of finasteride in preventing prostate cancer   Androgen deprivation therapy does not prevent prostate cancer from spreading   Predictive model of prostate cancer risk   Prostate cancer screening still unproven: report   Severe Form of “Enlarged Prostate” Disease Discovered   Young men with prostate cancer benefit from radiation therapy

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]